trending Market Intelligence /marketintelligence/en/news-insights/trending/xrvxb_hvpiegoy_8w76bta2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

US FTC conditionally approves Abbott's $25B acquisition of St. Jude Medical

Cable Nets For Kids Enjoy Wide Carriage On Skinny Bundles

Energy

Power Forecast Briefing: Fleet Transformation, Under-Powered Markets, and Green Energy in 2018

Street Talk Episode 50 - Challenging The Legacy Core Bank Providers

Fed Poised To Relax Key Rules For Large Banks


US FTC conditionally approves Abbott's $25B acquisition of St. Jude Medical

The U.S. Federal Trade Commission conditionally approved Abbott Laboratories' proposed acquisition of fellow competitor St. Jude Medical Inc. in a deal valued at $25 billion.

Abbott is required to sell its steerable sheath business to Terumo Corp., while St. Jude will off-load its vascular closure device business to the Tokyo-based medical device maker to appease the regulator's anti-competitive concerns.

The companies agreed in principle to sell the businesses to Terumo for $1.12 billion in October.

Vascular closure devices are used to close holes made in an artery and prevent bleeding. Steerable sheaths are used to help position catheters into the heart.